Am J Med February 2017 PMID 27793642

Role of Niacin in Current Clinical Practice: A Systematic Review.

Aakash Garg, Abhishek Sharma, Parasuram Krishnamoorthy, Jalaj Garg, Deepti Virmani, Toishi Sharma, Giulio Stefanini, John B Kostis, Debabrata Mukherjee, Ekaterina Sikorskaya

Mentions

11
Peak: 1 in Jun 2022
across 5 sources since Jun 2022

Extended reach

925,839
potential audience

Total likes

17,345

Video views

903,332

Mentions per month

Jun 2022 – May 2024

Where it's discussed

  • Facebook3 posts
  • News3 articles
  • YouTube2 videos
  • Blogs2 articles
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussions reflect a neutral stance, with phrases like 'رور النياسين' (meaning 'I agree') indicating general acknowledgment but not strong convictions, and mentions of the 'clinical relevance' hinting at some interest. The tone is straightforward, with minimal depth, showing moderate interest in the article’s content and potential implications.

AgreementNeither agree nor disagree

The posts show neutrality, neither strongly supporting nor opposing the findings, reflecting a lack of clear consensus.

InterestModerate interest

The discussion indicates moderate curiosity, especially around the implications for clinical practice, but not intense enthusiasm.

EngagementNeutral engagement

Comments are brief and limited, suggesting a surface-level engagement without deep analysis or extensive discussion.

ImpactNeutral impact

The posts do not suggest a significant shift in opinions or practice, implying a marginal influence of the publication on broader debates.

Abstract in brief

  • This systematic review examined whether niacin, a drug known to increase good cholesterol (HDL), effectively reduces the risk of heart-related events and mortality, considering recent large trials showing no benefit.
  • The analysis of 13 trials with over 35,000 patients found that while niacin raises HDL levels, it does not significantly decrease overall death rates but may trend toward reducing some cardiovascular events like heart attacks, strokes, and need for procedures.
  • Overall, the evidence suggests that despite improving cholesterol profiles, niacin does not significantly lower mortality or prevent recurrent cardiovascular events in current clinical practice.

Top posts

Most liked on X and Bluesky
سعد المحارب
@5ymah · X

@AHMEDALZAMER @DietArab دور النياسين في القلب والكلسترول والضغط https://t.co/wiOjfuva2p

Jun 22, 2022 · 22,508 followers View post →

All mentions

سعد المحارب
@5ymah · X

@AHMEDALZAMER @DietArab دور النياسين في القلب والكلسترول والضغط https://t.co/wiOjfuva2p

Jun 22, 2022 · 22,508 followers View post →